B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN
Elena GagliardiniGiuseppe Remuzzi

Abstract

The incidence of progressive kidney disease associated with diabetes continues to rise worldwide. Current standard therapy with angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers achieves only partial renoprotection, increasing the need for novel therapeutic approaches. Previous studies described B7-1 induction in podocytes of patients with proteinuria, including those with FSGS and type 2 diabetic nephropathy (DN). These findings sparked great excitement in the renal community, implying that abatacept, a costimulatory inhibitor that targets B7-1, could be a novel therapy for diabetic renal disease. Given previous concerns over the value of B7-1 immunostaining and the efficacy of abatacept in patients with recurrent FSGS after renal transplantation, we investigated B7-1 expression in human and experimental DN before embarking on clinical studies of the use of B7-1 targeting strategies to treat proteinuria in DN. Immunohistochemical analysis of kidney specimens using different antibodies revealed that B7-1 is not induced in podocytes of patients with DN, independent of disease stage, or BTBR ob/obmice, a model of type 2 diabetes. These results do not support the use of abatacept as a therapeutic strate...Continue Reading

References

Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B PulendranJ Banchereau
Apr 12, 2002·The New England Journal of Medicine·Giuseppe RemuzziPiero Ruggenenti
May 2, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Qiong WuHideto Sakai
Nov 2, 2004·The New England Journal of Medicine·Piero RuggenentiUNKNOWN Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Sep 1, 2005·Circulation·Jackie BoschUNKNOWN HOPE/HOPE-TOO Study Investigators
Sep 16, 2005·The New England Journal of Medicine·Mark C GenoveseMaxime Dougados
Mar 28, 2006·Journal of the American Society of Nephrology : JASN·Giuseppe RemuzziPiero Ruggenenti
Aug 14, 2009·American Journal of Physiology. Renal Physiology·Elena GagliardiniAriela Benigni
Feb 20, 2010·Journal of the American Society of Nephrology : JASN·Thijs W Cohen TervaertUNKNOWN Renal Pathology Society
Jul 17, 2010·Journal of the American Society of Nephrology : JASN·Kelly L HudkinsCharles E Alpers
Apr 26, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Diana MittagLeonard C Harrison
Jun 11, 2011·Contributions to Nephrology·Behzad NajafianAgnes B Fogo
May 28, 2013·The American Journal of Pathology·Elena GagliardiniAriela Benigni
Nov 12, 2013·The New England Journal of Medicine·Chih-Chuan YuPeter Mundel
Mar 29, 2014·The New England Journal of Medicine·Anna GrekaPeter Mundel
Mar 29, 2014·The New England Journal of Medicine·Nada AlachkarJochen Reiser
Mar 29, 2014·Journal of the American Society of Nephrology : JASN·Paolo FiorinaMohamed H Sayegh
Apr 16, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·P CassisM Noris
Oct 4, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Christopher P LarsenPatrick D Walker
Dec 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F John Gennari

❮ Previous
Next ❯

Citations

Jun 18, 2016·BioMed Research International·Ben SprangersGerald Appel
Dec 25, 2015·Journal of the American Society of Nephrology : JASN·Marianne DelvilleGuillaume Canaud
Aug 17, 2016·Kidney International·Emilie BayeGuillaume Canaud
Mar 13, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Xuefei Tian, Shuta Ishibe
May 26, 2017·Arthritis & Rheumatology·Ian R Rifkin, Ramon G Bonegio
Oct 13, 2017·Clinical and Experimental Nephrology·Bhavya KhullarShailaja Sopory
Mar 2, 2018·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gabriel Cara-FuentesRichard J Johnson
Nov 17, 2015·Nature Reviews. Nephrology·Gerald B Appel
Aug 2, 2017·Clinical Science·Greg H Tesch
Feb 13, 2019·Clinical Kidney Journal·Hassan IzzedineIsabelle Brocheriou
Mar 20, 2019·Der Internist·J Müller-DeileM Schiffer
Jul 1, 2018·Nature Reviews. Nephrology·Rubina NovelliGiuseppe Remuzzi
Aug 8, 2018·Frontiers in Endocrinology·Mark A Lal, Jaakko Patrakka
Jun 26, 2018·Biochemical Pharmacology·Saikat Dewanjee, Niloy Bhattacharjee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Nephrology
Elena GagliardiniAriela Benigni
The New England Journal of Medicine
Chih-Chuan YuPeter Mundel
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Udom Krairittichai, Viranya Chaisuvannarat
© 2021 Meta ULC. All rights reserved